日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages increased bedaquiline resistance

结核分枝杆菌MmpS5L5外排泵的结构和功能分析预示着贝达喹啉耐药性的增加。

Fountain, Adam J; Böhning, Jan; McLaughlin, Stephen H; Morgan, Tomos E; Edelstein, Paul H; Troll, Mark; Lamers, Meindert H; Bharat, Tanmay A M; Luisi, Ben F; Ramakrishnan, Lalita

Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity.

维拉帕米及其代谢物去甲维拉帕米抑制结核分枝杆菌MmpS5L5外排泵,从而增加贝达喹啉的活性

Fountain Adam J, Waller Natalie J E, Cheung Chen-Yi, Jowsey William, Chrisp Michael T, Troll Mark, Edelstein Paul H, Cook Gregory M, McNeil Matthew B, Ramakrishnan Lalita

Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2

阿莫西林-克拉维酸钾抗流感嗜血杆菌折点:临床和实验室标准协会修订的理由<sup>2</sup>

Narayanan, Navaneeth; Mathers, Amy J; Wenzler, Eric; Moore, Nicholas M; Giske, Christian G; Mendes, Rodrigo E; Edelstein, Paul H

Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute

阿莫西林-克拉维酸钾抗肠杆菌科细菌折点:临床和实验室标准协会修订的理由

Narayanan, Navaneeth; Mathers, Amy J; Wenzler, Eric; Moore, Nicholas M; Giske, Christian G; Mendes, Rodrigo E; Edelstein, Paul H

A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis

一项剂量探索研究,旨在指导维拉帕米作为结核病辅助治疗药物的使用

Padmapriyadarsini, Chandrasekaran; Szumowski, John D; Akbar, Nabila; Shanmugasundaram, Prema; Jain, Anilkumar; Bathragiri, Marasamy; Pattnaik, Manoranjan; Turuk, Jyotirmayee; Karunaianantham, Ramesh; Balakrishnan, Senthilkumar; Pati, Sanghamitra; Kumar, A K Hemanth; Rathore, Manoj Kumar; Raja, Jegadeesh; Naidu, K Raghu; Horn, John; Whitworth, Laura; Sewell, Roger; Ramakrishnan, Lalita; Swaminathan, Soumya; Edelstein, Paul H

A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis

一项剂量探索研究,旨在指导维拉帕米作为结核病辅助治疗药物的使用

Padmapriyadarsini, Chandrasekaran; Szumowski, John D; Akbar, Nabila; Shanmugasundaram, Prema; Jain, Anilkumar; Bathragiri, Marasamy; Pattnaik, Manoranjan; Turuk, Jyotirmayee; Karunaianantham, Ramesh; Balakrishnan, Senthilkumar; Pati, Sangamitra; Agibothu Kupparam, Hemanth K; Rathore, Manoj Kumar; Raja, Jegadeesh; Naidu, K Raghu; Horn, John; Whitworth, Laura; Sewell, Roger; Ramakrishnan, Lalita; Swaminathan, Soumya; Edelstein, Paul H

Latent Tuberculosis: Two Centuries of Confusion

潜伏性结核病:两个世纪的混乱

Behr, Marcel A; Kaufmann, Eva; Duffin, Jacalyn; Edelstein, Paul H; Ramakrishnan, Lalita

Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone

结核性脑膜炎患者脑脊液细胞因子水平升高可预测地塞米松治疗后的生存率

Whitworth, Laura J; Troll, Rajan; Pagán, Antonio J; Roca, Francisco J; Edelstein, Paul H; Troll, Mark; Tobin, David M; Phu, Nguyen Hoan; Bang, Nguyen Duc; Thwaites, Guy E; Thuong, Nguyen Thuy Thuong; Sewell, Roger F; Ramakrishnan, Lalita

Improbable Results of Urine Isolate Antimicrobial Susceptibility Testing

尿液分离株抗菌药物敏感性试验的异常结果

Edelstein, Paul H; Humphries, Romney M

Azithromycin Phenotypic versus Clinical Resistance

阿奇霉素表型耐药性与临床耐药性

Edelstein, Paul H